Sentec
Michael Ballmann is a seasoned communications professional with extensive experience in corporate communications and marketing. Currently serving as a Content Marketing Specialist at Sentec since May 2023, Michael previously owned and operated Ballmann CPC as a Corporate Communications Consultant from July 2019 to May 2023. With a notable tenure at Roche from 2011 to 2017, Michael held various roles including Head of CEO Roche Diagnostics Office Communications, where responsibilities encompassed managing executive communications, business strategy communications, and crisis communications projects. Michael’s earlier experience includes positions at Ballmann Communications & Publishing, c-public GmbH, text:ballmann, and UBS, further solidifying expertise in corporate communications management. Educational credentials include a Master in Advanced Studies from the University of Applied Sciences and Arts Northwestern Switzerland and a Certificate in Web Development from the University of Basel, along with proficiency in English.
This person is not in any teams
This person is not in any offices
Sentec
1 followers
Founded in 1999, SenTec AG is a medical device company which develops, manufactures and markets technologies and products for noninvasive patient monitoring. SenTec AG gained attention and worldwide appreciation due to its digital, combined transcutaneous sensors enabling noninvasive and continuous ventilation and oxygenation monitoring. SenTec AG meanwhile has become a prominent player in this field with its products and solutions being used in healthcare environments worldwide. For the future SenTec AG intends to become a dominant player in the fast-growing field of noninvasive patient monitoring and, consequently, adopted Advancing Noninvasive Patient Monitoring™ as its vision statement.